MedTrace Logo

Hematological Disorder in Patients With Angiodysplasia

NCT06050798 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 55

Last updated 2024-05-02

No results posted yet for this study

Summary

The study aim will be to assess the association between GIT angiodysplasia with any hematological disorders such as any specific coagulation disorders or anemia.

Conditions

  • Angiodysplasia
  • Hematological Disease

Interventions

DIAGNOSTIC_TEST

Von willebrand antigen

Von willebrand antigen change and hematological disorder in patients with angiodysplasia

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • AbdelHamid Mohamed AbdelHamid Aly · Assiut University

  • Nabeela Faiek Amin Mousa · Assiut University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-01
Primary Completion
2026-09-01
Completion
2026-10-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06050798 on ClinicalTrials.gov